Catalent, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of
advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, today announced that John
Chiminski, President & Chief Executive Officer, and Matthew Walsh,
Executive Vice President & Chief Financial Officer, will present at the
Morgan Stanley 2014 Global Healthcare Conference at 12:55 p.m. ET on
Wednesday, September 10, 2014.
A live webcast of Catalent’s presentation can be accessed from the
Company’s website at www.catalent.com
and will be available for replay later that day.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs more than 8,000
people, including over 1,000 scientists, at nearly 30 facilities across
5 continents. Catalent is headquartered in Somerset, N.J. For more
information, please visit www.catalent.com.
Forward-Looking Statements
This press release contains both historical and forward-looking
statements. All statements other than statements of historical fact are,
or may be deemed to be, forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended. These
forward-looking statements generally can be identified by the use of
statements that include phrases such as “believe,” “expect,”
“anticipate”, “intend”, “estimate”, “plan”, “project”, “foresee”,
“likely”, “may”, “will”, “would” or other words or phrases with similar
meanings. Similarly, statements that describe our objectives, plans or
goals are, or may be, forward-looking statements. These statements are
based on current expectations of future events. If underlying
assumptions prove inaccurate or unknown risks or uncertainties
materialize, actual results could vary materially from Catalent, Inc.’s
expectations and projections. Some of the factors that could cause
actual results to differ include, but are not limited to, the following:
general industry conditions and competition; product or other liability
risk inherent in the design, development, manufacture and marketing of
our offerings; inability to enhance our existing or introduce new
technology or services in a timely manner; economic conditions, such as
interest rate and currency exchange rate fluctuations; technological
advances and patents attained by competitors; and our substantial debt
and debt service requirements that restrict our operating and financial
flexibility and impose significant interest and financial costs. For a
more detailed discussion of these and other factors, see the information
under the caption “Risk Factors” in our Prospectus dated July 30, 2014
filed with the Securities and Exchange Commission. All forward-looking
statements speak only as of the date of this release or as of the date
they are made, and Catalent, Inc. does not undertake to update any
forward-looking statements as a result of new information or future
events or developments unless required by law.
More products. Better treatments. Reliably supplied.™
Investor:
Bertner Advisors, LLC
Monique Kosse, 860-940-0352
Monique.Kosse@BertnerAdvisors.com